- Home
- DCTH vs ASA Comparison
DCTH vs ASA Comparison
Compare DCTH & ASA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- ASA
- Stock Information
- Founded
- DCTH 1988
- ASA 1958
- Country
- DCTH United States
- ASA United States
- Employees
- DCTH N/A
- ASA N/A
- Industry
- DCTH Medical/Dental Instruments
- ASA Precious Metals
- Sector
- DCTH Health Care
- ASA Industrials
- Exchange
- DCTH Nasdaq
- ASA Nasdaq
- Market Cap
- DCTH 630.4M
- ASA 549.0M
- IPO Year
- DCTH N/A
- ASA N/A
- Fundamental
- Price
- DCTH $16.30
- ASA $33.70
- Analyst Decision
- DCTH Strong Buy
- ASA
- Analyst Count
- DCTH 4
- ASA 0
- Target Price
- DCTH $24.00
- ASA N/A
- AVG Volume (30 Days)
- DCTH 610.5K
- ASA 57.6K
- Earning Date
- DCTH 05-08-2025
- ASA 06-10-2025
- Dividend Yield
- DCTH N/A
- ASA 0.15%
- EPS Growth
- DCTH N/A
- ASA N/A
- EPS
- DCTH N/A
- ASA 11.67
- Revenue
- DCTH $53,850,000.00
- ASA $3,557,386.00
- Revenue This Year
- DCTH $141.47
- ASA N/A
- Revenue Next Year
- DCTH $49.31
- ASA N/A
- P/E Ratio
- DCTH N/A
- ASA $2.71
- Revenue Growth
- DCTH 1068.87
- ASA 45.39
- 52 Week Low
- DCTH $6.33
- ASA $16.97
- 52 Week High
- DCTH $18.23
- ASA $34.19
- Technical
- Relative Strength Index (RSI)
- DCTH 58.68
- ASA 70.29
- Support Level
- DCTH $15.73
- ASA $31.24
- Resistance Level
- DCTH $17.29
- ASA $31.93
- Average True Range (ATR)
- DCTH 0.96
- ASA 0.78
- MACD
- DCTH -0.08
- ASA 0.31
- Stochastic Oscillator
- DCTH 50.58
- ASA 93.40
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About ASA ASA Gold and Precious Metals Limited
ASA Gold And Precious Metals Ltd is a closed-end, non-diversified investment company. Its objective is to provide long-term capital appreciation through investing in companies engaged in the exploration for, development of projects, or mining of precious metals and minerals.